Expression of p53 protein in psoriasis
- PMID: 16200332
Expression of p53 protein in psoriasis
Abstract
Introduction: Psoriasis is characterized by hyperproliferation and abnormal differentiation of keratinocytes,by the presence of inflammatory cell infiltrate in both the dermis and the epidermis and by alterations of capillaries. p53 protein is an important transcription factor which plays a central role in cell cycle regulation mechanisms and cell proliferation control.
Objectives: This study was performed to identify the expression and localization of p53 protein in lesional and non-lesional skin samples taken from psoriatic patients in comparison with healthy controls.
Material and methods: Sections of psoriatic lesional and non-lesional skin (n=18) were examined. A control group (n=10) of healthy volunteers with no personal and family history of psoriasis was also examined. The expression of p53 was demonstrated using the avidin-biotin complex immunoperoxidase method and the monoclonal antibody DO7. The count and localization of cells with stained nuclei was evaluated using a light microscope in 10 fields for every skin biopsy.
Results: In lesional psoriatic skin the count of p53 positive cells was significantly higher than in the skin samples taken from healthy individuals (p<0.01) and non-lesional skin taken from psoriatic patients (p=0.02). No significant difference between non-lesional psoriatic skin and normal skin was observed (p=0.1). A strong positive correlation between mean count and mean per cent of p53 positive cells was found (p<0.0001). P53 positive cells were located most commonly in the basal layer of the epidermis of both healthy skin and non-lesional psoriatic skin. In lesional psoriatic skin p53 positive cells were present in all layers of the epidermis.
Conclusion: P53 protein appears to be an important factor in the pathogenesis of psoriasis.
Similar articles
-
Expression of p53 in lesions and unaffected skin of patients with plaque-type and guttate psoriasis: a quantitative comparative study.J Dermatol. 2007 Jun;34(6):367-74. doi: 10.1111/j.1346-8138.2007.00290.x. J Dermatol. 2007. PMID: 17535401 Review.
-
Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis.Arch Dermatol Res. 2011 Aug;303(6):389-97. doi: 10.1007/s00403-011-1125-0. Epub 2011 Jan 29. Arch Dermatol Res. 2011. PMID: 21279373
-
Inverse regulation of the nuclear factor-kappaB binding to the p53 and interleukin-8 kappaB response elements in lesional psoriatic skin.J Invest Dermatol. 2005 Jun;124(6):1284-92. doi: 10.1111/j.0022-202X.2005.23749.x. J Invest Dermatol. 2005. PMID: 15955105
-
Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin.Int J Mol Med. 2011 Nov;28(5):785-92. doi: 10.3892/ijmm.2011.757. Epub 2011 Jul 25. Int J Mol Med. 2011. PMID: 21805023
-
Role of Skin pH in Psoriasis.Curr Probl Dermatol. 2018;54:108-114. doi: 10.1159/000489524. Epub 2018 Aug 21. Curr Probl Dermatol. 2018. PMID: 30130779 Review.
Cited by
-
Immunohistochemical expression of P53, Ki-67, and CD34 in psoriasis and psoriasiform dermatitis.Biomedicine (Taipei). 2019 Dec;9(4):26. doi: 10.1051/bmdcn/2019090426. Epub 2019 Nov 14. Biomedicine (Taipei). 2019. PMID: 31724940 Free PMC article.
-
MTHFR C677T rs1801133 and TP53 Pro72Arg rs1042522 gene variants in South African Indian and Caucasian psoriatic arthritis patients.Genet Mol Biol. 2025 Jan 10;48(1):e20230325. doi: 10.1590/1678-4685-GMB-2023-0325. eCollection 2025. Genet Mol Biol. 2025. PMID: 39792433 Free PMC article.
-
CD200/CD200 receptor axis in psoriasis vulgaris.PLoS One. 2020 Mar 23;15(3):e0230621. doi: 10.1371/journal.pone.0230621. eCollection 2020. PLoS One. 2020. PMID: 32203537 Free PMC article.
-
Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease.Front Immunol. 2018 Jul 10;9:1485. doi: 10.3389/fimmu.2018.01485. eCollection 2018. Front Immunol. 2018. PMID: 30042760 Free PMC article.
-
The Expression of Cytokines and Chemokines Potentially Distinguishes Mild and Severe Psoriatic Non-Lesional and Resolved Skin from Healthy Skin and Indicates Different Stages of Inflammation.Int J Mol Sci. 2024 Oct 20;25(20):11292. doi: 10.3390/ijms252011292. Int J Mol Sci. 2024. PMID: 39457071 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous